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DIFFERENTIAL EXPRESSION OF RLRS IN THE HUMAN PLACENTA 
ACROSS GESTATION 
SARAH JESSICA CAPLAN 
ABSTRACT 
 After the discovery that Zika virus (ZIKV) infection in pregnant women may 
result in severe adverse outcomes such as fetal microcephaly, ZIKV must be added to an 
ever-expanding list of teratogenic viruses. As only a small minority of newborns will 
display congenital abnormalities after maternal primary infection, innate immune 
mechanisms must exist in the placenta to prevent viral transmission to the fetus. 
Understanding the innate antiviral defenses of the placenta is critical to improving 
diagnosis, treatment, and prevention of adverse pregnancy outcomes stemming from viral 
infections. 
 We hypothesized that RLRs are expressed in either one or both of the outer cell 
layers of the chorionic villi, either the syncytiotrophoblast (STB, outermost layer) or in 
the villous cytotrophoblast (CTB, inner layer), and that expression of these receptors will 
increase with advancing gestational age.  In order to determine the expression of RLRs in 
placental tissue (6-32 weeks and full-term), we used immunohistochemistry to stain for 
the RIG-I-like receptors (RLRs) RIG-I, DHX58/LGP2, and MDA5, as well as the 
endosomal Toll-like receptor TLR7, that serve as antiviral innate immune receptors 
involved in detecting microbial ligands and cytoplasmic viral nucleic acids. Hofbauer 
(HB) cells stained positive for all receptors and served as a positive internal control. 
 TLR7 was not present in either the STB or CTB throughout gestation. MDA5 was 
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localized to the STB cytoplasm up to 13 weeks. After 13 weeks, MDA5 was localized to 
the CTB cytoplasm. DHX58/LGP2 was localized to the STB cytoplasm at 6 weeks of 
gestation, the STB apical and basal membranes in addition to cytoplasm at 7 weeks of 
gestation, and also CTB cytoplasm after 7 weeks of gestation. Lastly, RIG-I was 
localized to the CTB cytoplasm throughout gestation. 
 The differential expression of these RLRs suggest an innate immune defense 
system unique to the placenta that is responsible for protecting the conceptus from viral 
attack.  These findings will complement ongoing work in characterizing replication of 
teratogenic viruses in the placenta. 
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INTRODUCTION 
Development of the trophoblast layers of the placenta 
 Fertilization of the female oocyte with the male sperm forms a diploid zygote that 
undergoes multiple cycles of cell cleavage. The cells migrating towards the periphery 
form the trophoblast (outer cell mass), and the cells that migrate centrally form the 
embryoblast (inner cell mass). The embryoblast gives rise to all cells and tissues of the 
embryo, whereas the trophoblast lineage gives rise to the fetal portion of the placenta. 
The polar trophoblast, the area of the trophoblast that overlies the embryoblast, attaches 
to the uterine lining. Inappropriate blastocyst rotation may cause attachment of the 
blastocyst to the uterine lining at an area other than the polar trophoblast and abnormal 
umbilical cord insertion (Huppertz, 2008). 
 After attachment, the trophoblast further differentiates into two cell layers called 
the syncytiotrophoblast (STB) and villous cytotrophoblast (CTB). The STB is a 
syncytium of non-mitotic, multinucleated cells that serve as an interface between the 
blastocyst and the mother, where nutrient and gas exchange take place and proteins are 
produced. The CTB is a layer of mitotic, mononucleated cells underlying the STB. The 
CTB differentiates into STB and extravillous cytotrophoblasts that contribute to placental 
invasion throughout gestation; fusion of CTB into multinucleated cells creates the STB 
layer  (Huppertz, 2008).  
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Figure 1. Schematic of the blastocyst during implantation as it begins to form the 
STB and CTB. Taken from Huppertz, 2008. 
 
Establishment of the maternal-fetal interface 
As the STB invades the maternal vasculature, lacunae form within the STB and fill with 
maternal blood. These lacunae merge together to allow maternal blood to circulate to the 
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embryo. The extravillous CTB sends finger-like projections into the maternal decidual 
tissue that eventually grow into multilayered units called chorionic villi that invade into 
maternal blood vessels, and a uteroplacental circulatory system is established	(Huppertz, 
2008). 	
 The connection of maternal and fetal circulatory systems allows transfer of 
nutrients, gases, and waste products between the fetus and mother throughout pregnancy. 
Microvilli on the apical surface of the STB increase this surface area seven-fold, making 
this exchange even more efficient (Huppertz, 2008). The STB expresses transporters on 
the apical microvillous membrane that faces the mother, transporters on the basal 
membrane that faces the fetus, and cytosolic metabolic enzymes. It has been thought that 
abnormal regulation of these processes may result in poor fetal development and/or 
disease occurrence later in life (Staud & Karahoda, 2018). 	 
 
Immune activity at the maternal fetal interface 
 Due to the chimeric nature of the placenta, immune activity at the maternal-fetal 
interface must be tightly regulated. On one hand, the maternal immune response must be 
dampened enough to allow maternal tolerance of the fetal allograft. Dampening of the 
immune response is accomplished after implantation by proliferation of regulatory T-
cells that create an anti-inflammatory environment. Because parturition is a pro-
inflammatory state, it is thought that a premature shift from an anti-inflammatory state to 
a pro-inflammatory state results in preterm labor and delivery (Vora et al., 2018, p.).  
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 On the other hand, there must be a robust enough immune response to defend the 
fetoplacental unit from infection. The STB serves as the first line of defense against any 
invader and therefore must be able to prevent pathogens from infecting the fetoplacental 
unit. For example, the STB normally resists infection by Group B Coxsackie Virus 
(CBV), Parvovirus B19 (PV), Varicella Virus (VSV), Herpes Simplex Virus (HSV) 1 and 
2, Cytomegalovirus (CMV), and Human Immunodeficiency Virus (HIV). Pathogens that 
bypass the STB layer can enter the CTB and infect the remainder of the fetoplacental 
unit. The CTB is especially susceptible to infection by CMV, HSV, Hepatitis C virus 
(HCV), HIV, and CBV (Delorme-Axford, Sadovsky, & Coyne, 2014).  
 Of these viruses, HCV is the world’s most common bloodborne virus. Human 
trophoblast cells express receptors that allow HCV binding and entry and are permissive 
to HCV uptake. Thus, preventing transmission from infected mother to fetus is difficult. 
Vertical transmission upregulates the inflammatory antiviral response that may cause 
preterm delivery and perinatal mortality (Giugliano et al., 2015).  
 Similarly, HSV-1 is one of the most common sexually transmitted viruses among 
adult women. HSV-1 vertical transmission is rare, but when it does occur, it results in 
severe adverse pregnancy outcomes including fetal abortion, congenital malformations, 
and stillbirth (Jabłońska, Studzińska, Suski, Kalinka, & Paradowska, 2018). The severity 
of these pregnancy outcomes emphasizes the importance of understanding the innate 
antiviral defenses of the placenta to improve diagnosis, treatment, and prevention. 
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Pattern recognition receptors: TLRs and RLRs 
 The antiviral response of the placenta involves innate immune receptors. These 
receptors are known as intracellular pattern recognition receptors (PRRs). PRRs 
recognize pathogen-associated molecular patterns (PAMPs) and mount an immune 
response. PRRs include Toll-like receptors (TLRs) 1-9 and retinoic acid-inducible gene 
(RIG)-I like receptors (RLRs). RLRs include RIG-I, melanoma differentiation-associated 
protein 5 (MDA5) and Laboratory of Genetics and Physiology 2 (LGP2), also known as 
DExH-box helicase 58 (DHX58) (Bryant et al., 2017). 
 
TLRs: Function and mechanisms of action  
 TLRs detect microbial ligands. TLRs -1, -2, -4, -5, and -6 are cell surface 
receptors. TLRs -3, -7, -8, and -9 are endosomal receptors. TLR2 combined with TLR1 
or TLR6 recognizes bacterial lipoproteins and lipoteichoic acid.  TLR3 recognizes viral 
double stranded RNA (dsRNA).  TLR4 recognizes lipopolysaccharides (LPS).  TLR5 
recognizes flagellin.  TLR7 and TLR8 recognize single stranded RNA (ssRNA).;  TLR9 
senses bacterial DNA through recognition of CpG enriched double stranded DNA 
(dsDNA) (Pudney et al., 2016).  
 Upon recognition of the ligand, TLRs dimerize and the Toll/IL-1 receptor (TIR) 
domains come into closer proximity. The new signaling domain recruits TIR domain-
containing adaptor molecules to the cell membrane. The assembly of proteins formed at 
the plasma membrane initiates a signaling cascade that results in the phosphorylation and 
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activation of various transcription factors that activate an anti-microbial response to 
stymie infection (Unterholzner & Bowie, 2008). 
 TIR domain-containing adaptor molecules and transcription factors are specific to 
TLR subtype. TLRs -1, -2, -4, -5, -6, -7, -8, and -9 recruit Myeloid differentiation factor 
88 (Myd88) to the cell membrane. Recruitment of Myd88 activates the nuclear factor 
kappa-light-chain enhancer of activated B cells (NF-𝜅B) pathway that induces 
transcription of inflammatory cytokines (Koga & Mor, 2008). Pro-inflammatory 
cytokines mediate the innate immune response by upregulating host defenses against 
pathogens.  
 TLR-3 and -4 also mediate the innate immune response but can do so 
independently of Myd88. Following ligand recognition and receptor dimerization, TLR-3 
and -4 activate TIR domain-containing adaptor inducing IFN-𝛽 (TRIF). This protein 
activates the NF-𝜅B pathway and phosphorylates and activates IFN regulatory factor-3 
(IRF-3). IRF-3 induces expression of type I IFNs and other IFN-inducible genes (Koga & 
Mor, 2008). Similar to pro-inflammatory cytokines, interferons and IFN-inducible genes 
help regulate host defenses against pathogens.  
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Figure 2. Schematic of TLR signaling pathway. Adapted from Koga & Mor, 2008. 
 
 Chan & Guilbert, 2006 found that cultured trophoblast cells express TLR2 at 
steady state and upregulate expression of TLR2 when exposed to human cytomegalovirus 
(HCMV). HCMV binds TLR2 at the STB cell membrane and activates the NF-𝜅B 
inflammatory pathway. This receptor-ligand binding also induces apoptosis of 
trophoblast cells, that would be detrimental to the developing fetus (Chan & Guilbert, 
2006). Cells lacking TLR2 could not produce the appropriate antiviral response, as seen 
by a decrease in interleukins and other inflammatory cytokines (Compton et al., 2003). 
 In addition to detecting pathogen-derived ligands, TLRs can recognize 
endogenous host ligands such as reactive oxygen species (ROS), proteins released from 
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dead or dying cells, and extracellular matrix breakdown products (Koga & Mor, 2008). 
For example, preeclampsia (PE), a hypertensive syndrome that affects almost 10% of 
pregnancies, is thought to be caused by inadequate maternal tolerance of the fetus. This 
intolerance results in the release of endogenous host markers of cellular damage. These 
molecules activate TLR signaling that causes inappropriate immune activity at the 
maternal fetal interface. The resultant inflammation may result in morbidity and mortality 
in both mother and fetus (Chatterjee et al., 2012).  
 Chatterjee et al., 2012 found that compared to healthy pregnant women, placentas 
from PE women had increased immunoreactivity and mRNA expression of TLR-3, -7, 
and -8 in the STB and CTB. TLR -3, -7, and -8 agonists resulted in upregulation of all 
three receptor protein levels in in vitro human trophoblast cell activation. This activation 
leads to inflammation and immune cell activation via TLR signaling pathways. Pregnant 
mice treated with similar agonists exhibited inflammation, splenomegaly, fetal demise, 
and pregnancy-dependent hypertension and endothelial dysfunction. These results 
suggest that placental TLR3/7/8 activation is sufficient to cause PE  (Chatterjee et al., 
2012).  
 
RLRs: Function and mechanisms of action  
 RIG-I and MDA5 are cytoplasmic sensors of nucleic acid. RIG-I detects RNA 
through interactions with the phosphate-sugar backbone, whereas MDA5 detects RNA 
through recognition of a long internal RNA sequence (Reikine, Nguyen, & Modis, 2014). 
RIG-I and MDA5 undergo a conformational change when exposed to their specific 
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ligands. This conformational change exposes the N-terminal caspase-recruitment domain 
(CARD) of the receptor, that then binds the mitochondrial antiviral-signaling protein 
(MAVS). MAVS recruits the tumor necrosis factor (TNF) receptor-associated factor 3 
(TRAF3) and TNF receptor-associated factor 6 (TRAF6) to its C-terminal. This 
interaction activates downstream signaling proteins that upregulate expression of type I 
interferon (IFN) and other inflammatory cytokines and chemokines (Ma et al., 2018).  
 DHX58, also known as LGP2, shares a conserved sequence with RIG-I and 
MDA5, allowing it to also recognize viral RNA. However, unlike RIG-I and MDA5, 
DHX58/LGP2 does not have a CARD domain, so it cannot activate MAVS. Therefore, it 
is thought to have a regulatory role in RLR signaling.  
 Contradictory research exists that supports DHX58/LGP2 as either a positive or 
negative regulator of RLR signaling (Rodriguez, Bruns, & Horvath, 2014). Rothenfusser 
et al., found DHX58/LGP2 to be a negative regulator of RLR signaling. To study the 
effect of DHX58/LGP2, they infected human embryonic kidney (HEK) cells with Simian 
Virus (SV) and then transfected these cells with cDNA that expressed DHX58/LGP2 and 
an interferon sensitive response element (ISRE). They found that increasing expression of 
DHX58/LGP2 inhibited virus-induced ISRE activation in a dose-dependent manner. 
Next, they transfected SV-infected cells with cDNA that expressed eukaryotic initiation 
factor-4A (eIF4A), a distantly related DExD/H box RNA helicase, and an ISRE. eIF4A 
did not affect virus-induced ISRE activation. This finding supports the conclusion that 
DHX58/LGP2 acts as a negative regulator of RLR signaling (Rothenfusser et al., 2005).  
	10 
 In contrast, Rodriguez et al., 2014 found that DHX58/LGP2-/- mice are more 
susceptible to certain viral infections and have defective antiviral responses compared to 
their heterozygous littermates. This finding supports the claim that DHX58/LGP2 has a 
protective effect on viral replication by enhancing RLR signaling (Rodriguez et al., 2014) 
 The recent Zika Virus (ZIKV) epidemic in the Americas further establishes the 
importance of understanding early pregnancy biology in order to diagnose, prevent, and 
treat adverse pregnancy outcomes stemming from viral infections. ZIKV has been linked 
to severe neurological complications including neonatal microcephaly, adult Guillain-
Barre syndrome, and maculopathy. It has been shown that ZIKV circumvents antiviral 
defenses by turning off RLR signaling at the maternal-fetal interface. Ma et al., 2018 
used the CRISPR-Cas9 system to abolish MDA5, RIG-I, and MAVS protein expression 
in human trophoblast. After infection with ZIKV, they found that intracellular ZIKV 
RNA was moderately higher in RIG-/- and MDA5-/- cells compared to wild type (WT) 
cells, but was ~20-40 times higher in MAVS-/- cells compared to WT. They also found 
that IFN 𝛽1 mRNA was reduced ~7-fold in RIG-/- and MDA5-/- cells, but was almost 
completely absent in MAVS-/- cells compared to WT. Therefore, induction of IFN 
requires RLR signaling to resist ZIKV infection and replication in human trophoblast 
cells (Ma et al., 2018).  
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STUDY OBJECTIVES 
 The trophoblast is the first line of defense against pathogens threatening the 
fetoplacental unit. The trophoblast is able to fend off infection via innate immune 
mechanisms to protect the fetus from teratogenic infections in the majority of cases. RIG-
I-like receptors (RLRs) regulate this activity by recognizing pathogen-associated 
molecular patterns (PAMPs) and initiating an inflammatory response. We aim to 
characterize the expression of RLRs in the placenta throughout gestation. We hypothesize 
that RLRs are expressed in either one or both of the outer cell layers of the chorionic villi, 
either the syncytiotrophoblast (STB, outermost layer) or in the villous cytotrophoblast 
(CTB, inner layer), and that expression of these receptors will increase with advancing 
gestational age. 
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METHODS  
IRB-approved discarded human tissue collection 
 De-identified discarded human placental tissue was collected from pregnancy 
terminations in the Obstetrics & Gynecology ambulatory practice of Boston Medical 
Center under protocols H-36583 and H-31734 approved by the Boston University School 
of Medicine (BUSM) Institutional Review Board (IRB). 
 
Embedding 
 The collected placental tissue was immersed in buffered formalin for 24 h at room 
temperature. Tissue blocks were sequentially immersed in 70%, 95%, and 100% ethanol, 
followed by Pro-Par solution (xylene substitute) to dehydrate them. The samples were 
then embedded in molten paraffin. After the paraffin solidified, tissue-embedded blocks 
were kept at 4°C.  
 
Sectioning 
 Tissue-embedded paraffin blocks were placed on ice for at least 20 min each. 5 𝜇m-thick sections of the blocks were cut using a microtome, floated in a 50°C distilled 
water bath, and mounted onto Fisherbrand Superfrost Excell microscope slides. The 
slides were positioned upright in a slide rack and allowed to dry at room temperature.  
The slides were then dried in an oven at 37°C for at least 12 h. 
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Enzyme immunohistochemistry 
 Slides were immersed in Pro-Par and ethanol washes to deparaffinize and 
rehydrate the tissue. Slides were immersed in the Pro-Par solution four times for 5 min 
each, three times in 100% ethanol for 5 min each, once in 95% ethanol for 5 min, and 
once in 70% ethanol for 5 min. Slides were thoroughly rinsed in a stream of distilled 
water and then immersed in a distilled water bath for 5 min.  
 Slides were placed in a solvent-resistant container filled with 225 mL distilled 
water and 25 mL of Diva Decloaker 10X (Biocare Medical cat#DV2004MX) solution to 
enhance antibody-epitope binding. The container was placed in a pressure cooker 
(Biocare Medical cat#DC2002 Decloaking Chamber) filled with 500 mL distilled water 
and run according to manufacturer directions on SP1 and SP2 factory settings. 
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Figure 3. Settings of the Decloaking Chamber. Adapted from Biocare Medical. 
 Slides were rinsed in a stream of distilled water and then immersed in a distilled 
water bath for 5 min. Slides were quickly flicked dry, and the horizontal borders were 
marked with a hydrophobic pen (ImmEdge cat#H-4000). The slides were immediately 
transferred to and rinsed in 250 mL of tris-buffered saline (TBS) 1X solution 
(Immunocare TBS Wash Buffer 10X cat#TWB943M) for 5 min. Protein block (Dako 
Protein Block Serum-Free Code 10909) was applied to each slide at room temperature in 
a humidified chamber for 20 min.  
 Slides were flicked dry to remove the protein block, and the primary antibody 
(Abcam anti-RIG-I/DDX58 antibody ab45428, anti-MDA5 antibody ab79055, anti-TLR7 
antibody [EPR2088(2)] ab124928, or anti-DHX58/RLR antibody ab115674) solution, 
diluted in antibody diluent with background reducing components (Dako Code S3022), 
was added to each section. Negative controls received only the diluent solution without 
the primary antibody. Sections were incubated in the primary antibody solution in a 
humidified chamber for 1 h.  
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 Slides were transferred to and rinsed in TBS solution for 5 min. For rabbit 
antibodies only, the polymer (Biocare Medical MACH4 Universal AP Polymer Kit 
cat#M4U536) was applied to the slides at room temperature in a humidified chamber for 
30 min. Slides were transferred to and rinsed in 250 mL of 1X TBS solution for 5 min. 
One drop of fast-red was mixed with 2.5 mL Vulcan fast-red buffer (Biocare Medical 
Vulcan Fast Red Chromagen Kit 2) and applied to the slides. Development was 
monitored under the microscope to prevent under- or over-development of the tissue. 
Once adequately developed, the reaction was stopped by immersion of slides in distilled 
water.  
 Slides were rinsed in a stream of distilled water once all slides were developed. 
Slides were counterstained by dipping the slides in a hematoxylin solution for 3 sec. The 
reaction was immediately stopped by immersion of slides in cold tap water. Slides were 
rinsed in a stream of cold tap water and then re-rinsed with distilled water. After flicking 
the slides dry, glycerol (Dako Glycergel Mounting Medium Code C0563) was applied to 
the section, and a cover slip (Fisherfinest Premium Cover Glass cat#12-548-5M) was 
quickly applied on top of the glycerol.  
 
Fluorescence immunohistochemistry 
 Fluorescence immunohistochemistry (IHC) was used to confirm enzyme IHC 
results for DHX58/LGP2 staining. For fluorescence IHC, methods varied after primary 
antibody application. Fluorochrome Cy3 (red) fluorescence was applied for 45 min and 
then rinsed in phosphate-buffered saline solution (PBS). Nuclei were counterstained with 
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4’,6-diamidino-2’-phenylindole, dihydrochloride (DAPI) (blue) and analyzed under the 
fluorescence microscope in the dark. 	  
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RESULTS 
TLR7 is not expressed in the trophoblast layers at any gestational age 	 There was no TLR7 staining in the STB and CTB throughout gestation. Positive 
TLR7 staining of Hofbauer (HB) cells and granulocytes (when present) served as a 
positive internal control.  
 
Figure 4. Negative TLR7 staining in the STB and CTB throughout gestation. 
Positive TLR7 staining of Hofbauer (HB) cells and granulocytes (when present). 
Positive staining is indicated at the tip of the arrows. (A) 6w negative control. No TLR7 
staining of STB or CTB at 9w (B), 18w (C) or term (D). Positive TLR7 staining of HB 
cells and granulocytes (when present) throughout gestation. 
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MDA5 is expressed in the STB cytoplasm early in gestation and in the CTB cytoplasm 
later in gestation 
 Positive MDA5 staining of HB cells and granulocytes (when present) served as a 
positive internal control. MDA5 was localized to the STB cytoplasm until early 2nd 
trimester. Mid 2nd trimester, there was a transition from expression of MDA5 in the STB 
cytoplasm to expression of MDA5 in the CTB cytoplasm. 
 
Figure 5. Positive MDA5 staining in the STB and CTB is specific to gestational age. 
HB cells and granulocytes (when present) stain positive for MDA5 throughout 
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gestation. Positive staining is indicated at the tip of the arrows. Until early 2nd trimester, 
placenta showed positive MDA5 staining in the STB cytoplasm. (A) 6w is an example of 
positive MDA5 staining of the STB cytoplasm. Mid 2nd trimester, MDA5 is exclusively 
expressed in the CTB cytoplasm. 13w (B), 17w (C) and 21w (D) are examples of positive 
MDA5 staining in the CTB cytoplasm in mid-late 2nd trimester. The CTB is not well 
represented in later gestational ages, so only granulocytes stain positive for MDA5. 32w 
(E) and term (F) are examples of this trend. 
 
DHX58/LGP2 is expressed in the STB cytoplasm early in gestation and in the CTB 
cytoplasm later in gestation 
 Positive DHX58/LGP2 staining of HB cells and granulocytes (when present) 
served as a positive internal control. DHX58/LGP2 was localized to the STB cytoplasm 
in early 1st trimester. Late 1st trimester, there was a transition from expression of 
DHX58/LGP2 in the CTB cytoplasm to expression of DHX58/LGP2 at the STB apical 
membrane and the CTB cytoplasm.  
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Figure 6. Positive DHX58/LGP2 staining in the STB and CTB specific to gestational 
age. HB cells and granulocytes (when present) stain positive for DHX58/LGP2 
throughout gestation. Positive staining is indicated at the tip of the arrows. The STB 
cytoplasm stains positive for DHX58/LGP2 in early 1st trimester. (A) 6w is an example 
of early 1st trimester positive DHX58/LGP2 staining of the STB cytoplasm. Beginning 
late 1st trimester, and continuing throughout gestation, the STB apical membrane and 
CTB cytoplasm stain positive for DHX58/LGP2. (B) 7w shows positive DHX58/LGP2 
staining of STB apical and basal membranes mid-transition. 8w (C), 14w (D), and 19w 
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(E) are examples of positive DHX58/LGP2 staining of the STB apical membrane and 
CTB cytoplasm. CTB is not well represented in later gestational ages, so only 
granulocytes stain positive for DHX58/LGP2. Term (F) tissue is an example of this trend.  
 
 
Figure 7. Fluorescence immunohistochemistry to confirm enzyme 
immunohistochemistry results of DHX58/LGP2. Positive DHX58/LGP2 staining in 
the STB and CTB specific to gestational age. HB cells and granulocytes (when 
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present) stain positive for DHX58/LGP2 throughout gestation. Positive staining is 
indicated at the tip of the arrows. The STB cytoplasm stains positive for DHX58/LGP2 in 
early 1st trimester. (A) 6w is an example of early 1st trimester positive DHX58/LGP2 
staining of the STB cytoplasm. Beginning late 1st trimester, and continuing throughout 
gestation, the STB apical membrane and CTB cytoplasm stain positive for 
DHX58/LGP2. 8w (B), 9w (C), 10w (D) and 14w (E) are examples of positive 
DHX58/LGP2 staining of the STB apical membrane and CTB cytoplasm. 
 
RIG-I is expressed in the CTB cytoplasm throughout gestation 
 Positive RIG-I staining of Hofbauer cells and granulocytes (when present) served 
as a positive internal control. RIG-I was localized to the CTB cytoplasm throughout 
gestation. 
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Figure 8. Positive RIG-I staining in the CTB cytoplasm throughout gestation. HB 
cells and granulocytes (when present) stain positive for RIG-I throughout gestation. 
Positive staining is indicated at the tip of the arrows. (A) 8w, (B) 10w, (C) 14w, (D) 17w, 
and (E) 20w are examples of positive RIG-I staining in the CTB cytoplasm. The CTB is 
not well represented in later gestational ages, so there is only positive staining of 
granulocytes. Term (F) is an example of this trend.  
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DISCUSSION 
 
 Pregnancy is a time of delicate immune balance where inadequate immune 
defenses would allow pathogens to infect and potentially destroy the fetus, and also 
where excessive immune responses in the form of inflammatory cytokines may lead to 
preterm birth or other pregnancy disorders.  The trophoblast serves as the first line of 
defense against pathogens threatening to infect the fetoplacental unit. Therefore, the 
presence of innate immune receptors in the trophoblast is crucial to recognizing 
pathogens and defending the unit from infection. Our data show that RLRs are 
differentially expressed in the trophoblast throughout gestation. These results suggest that 
there is an innate immune defense system unique to the placenta that is responsible for 
protecting the conceptus from viral attack.  
Figure 9. Summary of TLR7, DHX58/LGP2, MDA5 and RIG-I staining results. 
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TLR7 is not expressed by the trophoblast throughout gestation. DHX58/LGP2 is 
expressed in the CTB cytoplasm in early 1st trimester. Beginning late 1st trimester, 
DHX58/LGP2 is expressed at the STB apical membrane and the CTB cytoplasm. MDA5 
is expressed in the STB cytoplasm until early 2nd trimester. Beginning mid 2nd trimester, 
there is a transition to MDA5 expression in the CTB cytoplasm. RIG-I is expressed in the 
CTB cytoplasm throughout gestation.  
 
 Although few, some placentas did not follow the common trend for expression of 
MDA5. Whereas the majority of placentas showed expression of MDA5 in the STB 
cytoplasm up to 13 weeks, one placenta showed expression of MDA5 in the CTB 
cytoplasm at 7 weeks. Whereas the majority of placentas showed expression of MDA5 in 
the CTB cytoplasm beginning at 13 weeks, two placentas also showed expression of 
MDA5 in the STB cytoplasm at 17 and 18 weeks. This variation may be attributed to 
imprecise estimation of gestational age, maternal infection and/or the progenitor cell 
nature of the CTB. Gestational age is estimated based on embryo size and last menstrual 
period. Visual estimation of embryo size is subject to human error, and menstruation is 
often irregular. We also do not have access to the mother’s medical history, so if 
infection was present in the mother, expression of innate immune receptors may be 
affected. Lastly, the mitotic CTB serves as a stem-cell reservoir for the amitotic STB. 
Therefore, it is difficult to say whether or not the STB synthesizes these proteins, or if the 
CTB synthesizes these proteins and passes them on to the STB as they become STB cells. 
 Our results with TLR7 differed from those of Bryant et al, who found trophoblast 
staining with TLR7 in non-labored term placental trophoblast and membranes, primarily 
chorion (Bryant et al 2017). Bryant el al also found strong expression of all three RLRs 
(RIG-I, MDA5, and DHX58/LGP2) in the trophoblasts, with expression of MDA5 and 
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DHX58/LGP2 in the villous stroma.  They did not differentiate between inner and outer 
trophoblast layers as we did, and only term unlabored placentas were evaluated in their 
study.  In contrast, we evaluated placentas over all three trimesters.  Differences in our 
findings may be due to differential antibody specificity, and we did not have labored or 
unlabored status of our term placentas.  We also employed immunofluorescence to ensure 
that findings could be replicated in a non-alkaline phosphatase-dependent method. 
 In the future, an improved understanding of the innate immune functions of the 
placenta may present new therapeutic targets for pregnancy-associated infections.   
Emerging viruses for which there are no vaccines are a major public health issue.  
Women who reside in areas endemic for teratogenic viruses such as Zika virus who 
desire pregnancy face unique challenges.  Novel treatment strategies such as RLR 
agonists may prove useful in conferring pan-antiviral protection, although safety 
concerns such uncontrolled immune activation must be addressed (Yong & Luo, 2018). 
  
	27 
REFERENCES 
Bryant, A. H., Menzies, G. E., Scott, L. M., Spencer-Harty, S., Davies, L. B., Smith, R. 
A., … Thornton, C. A. (2017). Human gestation-associated tissues express 
functional cytosolic nucleic acid sensing pattern recognition receptors. Clinical 
and Experimental Immunology, 189(1), 36–46.  
Chan, G., & Guilbert, L. J. (2006). Ultraviolet-inactivated human cytomegalovirus 
induces placental syncytiotrophoblast apoptosis in a Toll-like receptor-2 and 
tumour necrosis factor-α dependent manner. The Journal of Pathology, 210(1), 
111–120.  
Chatterjee, P., Weaver, L. E., Doersch, K. M., Kopriva, S. E., Chiasson, V. L., Allen, S. 
J., … Mitchell, B. M. (2012). Placental Toll-Like Receptor 3 and Toll-Like 
Receptor 7/8 Activation Contributes to Preeclampsia in Humans and Mice. PLOS 
ONE, 7(7), e41884. 
Compton, T., Kurt-Jones, E. A., Boehme, K. W., Belko, J., Latz, E., Golenbock, D. T., & 
Finberg, R. W. (2003). Human Cytomegalovirus Activates Inflammatory 
Cytokine Responses via CD14 and Toll-Like Receptor 2. Journal of Virology, 
77(8), 4588–4596. 
Delorme-Axford, E., Sadovsky, Y., & Coyne, C. B. (2014). The Placenta as a Barrier to 
Viral Infections. Annual Review of Virology, 1(1), 133–146.  
Giugliano, S., Petroff, M. G., Warren, B. D., Jasti, S., Linscheid, C., Ward, A., … Rosen, 
H. R. (2015). Hepatitis C Virus Sensing by Human Trophoblasts Induces Innate 
Immune Responses and Recruitment of Maternal NK Cells: Potential Implications 
	28 
for Limiting Vertical Transmission. The Journal of Immunology, 195(8), 3737–
3747.  
Huppertz, B. (2008). The anatomy of the normal placenta. Journal of Clinical Pathology, 
61(12), 1296–1302.  
Jabłońska, A., Studzińska, M., Suski, P., Kalinka, J., & Paradowska, E. (2018). Enhanced 
expression of IFI16 and RIG-I in human third-trimester placentas following HSV-
1 infection. Clinical & Experimental Immunology, 193(2), 255–263.  
Koga, K., & Mor, G. (2008). Review Article: Expression and Function of Toll-Like 
Receptors at the Maternal—Fetal Interface. Reproductive Sciences, 15(3), 231–
242.  
Ma, J., Ketkar, H., Geng, T., Lo, E., Wang, L., Xi, J., … Wang, P. (2018). Zika Virus 
Non-structural Protein 4A Blocks the RLR-MAVS Signaling. Frontiers in 
Microbiology, 9.  
Pudney, J., He, X., Masheeb, Z., Kindelberger, D. W., Kuohung, W., & Ingalls, R. R. 
(2016). Differential expression of toll-like receptors in the human placenta across 
early gestation. Placenta, 46, 1–10.  
Reikine, S., Nguyen, J. B., & Modis, Y. (2014). Pattern Recognition and Signaling 
Mechanisms of RIG-I and MDA5. Frontiers in Immunology, 5.  
Rodriguez, K. R., Bruns, A. M., & Horvath, C. M. (2014). MDA5 and LGP2: 
Accomplices and Antagonists of Antiviral Signal Transduction. Journal of 
Virology, 88(15), 8194–8200. 
	29 
Rothenfusser, S., Goutagny, N., DiPerna, G., Gong, M., Monks, B. G., Schoenemeyer, 
A., … Fitzgerald, K. A. (2005). The RNA Helicase Lgp2 Inhibits TLR-
Independent Sensing of Viral Replication by Retinoic Acid-Inducible Gene-I. The 
Journal of Immunology, 175(8), 5260–5268.  
Staud, F., & Karahoda, R. (2018). Trophoblast: The central unit of fetal growth, 
protection and programming. The International Journal of Biochemistry & Cell 
Biology, 105, 35–40. 
Unterholzner, L., & Bowie, A. G. (2008). The interplay between viruses and innate 
immune signaling: Recent insights and therapeutic opportunities. Biochemical 
Pharmacology, 75(3), 589–602.  
Vora, B., Wang, A., Kosti, I., Huang, H., Paranjpe, I., Woodruff, T. J., … Sirota, M. 
(2018). Meta-Analysis of Maternal and Fetal Transcriptomic Data Elucidates the 
Role of Adaptive and Innate Immunity in Preterm Birth. Frontiers in 
Immunology, 9, 993.  
Yong, H. Y., & Luo, D. (2018). RIG-I-Like Receptors as Novel Targets for Pan-
Antivirals and Vaccine Adjuvants Against Emerging and Re-Emerging Viral 
Infections. Frontiers in Immunology, 9.  	  
	30 
CURRICULUM VITAE 
	31 
	32 
	33 
